Dopamine, but not noradrenaline, contributes to opiate withdrawal-induced anxiety in the VTA
2010-12-21
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Dopamine, but not noradrenaline, contributes to opiate withdrawal-induced anxiety in the VTA
Authors
Published Date
2010-12-21
Publisher
Type
Presentation
Abstract
•Research in the Gewirtz laboratory has shown that one of the brain structures involved in mediating withdrawal from opiate drugs such as morphine is the ventral tegmental area(VTA). Morphine causes the VTA to release dopamine and excite downstream targets,which maybe related to the onset of withdrawal.
•In addition,increased levels of noradrenaline are also present during opiate withdrawal.3,4
•We aim to test whether both the dopaminergic and adrenergic systems engage to produce WPS when morphine is supplied to the VTA. Thus,we administer propranolol, an adrenergic receptor antagonist,to determine whether noradrenaline is recruited by the VTA during withdrawal. Apomorphine ,a dopamine agonist, is given to determine the actions of dopamine during withdrawal
Description
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Hupalo, Sofiya. (2010). Dopamine, but not noradrenaline, contributes to opiate withdrawal-induced anxiety in the VTA. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/98129.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.